Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $81.6 million.

  • Bioventus' Operating Expenses fell 438.91% to $81.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $327.3 million, marking a year-over-year decrease of 627.29%. This contributed to the annual value of $365.0 million for FY2024, which is 1051.45% up from last year.
  • Latest data reveals that Bioventus reported Operating Expenses of $81.6 million as of Q3 2025, which was down 438.91% from $82.3 million recorded in Q2 2025.
  • Bioventus' 5-year Operating Expenses high stood at $100.9 million for Q2 2024, and its period low was $35.6 million during Q2 2021.
  • Its 5-year average for Operating Expenses is $81.7 million, with a median of $82.3 million in 2025.
  • Per our database at Business Quant, Bioventus' Operating Expenses soared by 16275.92% in 2022 and then tumbled by 1869.31% in 2023.
  • Bioventus' Operating Expenses (Quarter) stood at $88.7 million in 2021, then fell by 0.76% to $88.0 million in 2022, then dropped by 7.33% to $81.5 million in 2023, then rose by 6.53% to $86.9 million in 2024, then dropped by 6.1% to $81.6 million in 2025.
  • Its last three reported values are $81.6 million in Q3 2025, $82.3 million for Q2 2025, and $76.5 million during Q1 2025.